$1.35
-0.05 (-3.57%)
Open$1.41
Previous Close$1.40
Day High$1.41
Day Low$1.20
52W High$3.20
52W Low$1.26
Volume—
Avg Volume87.0K
Market Cap70.85M
P/E Ratio—
EPS$-0.24
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,040.0% upside
Current
$1.35
$1.35
Target
$28.89
$28.89
$16.92
$28.89 avg
$30.86
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 9.01M | 9.02M | 8.76M |
| Net Income | -596,230 | -528,269 | -565,775 |
| Profit Margin | -6.6% | -5.9% | -6.5% |
| EBITDA | -746,119 | -716,524 | -642,558 |
| Free Cash Flow | -600,890 | -503,274 | -433,552 |
| Rev Growth | +12.0% | +12.6% | +22.9% |
| Debt/Equity | 0.77 | 0.69 | 0.70 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $295.03 | +0.20% | 50.3 | 520.47B |
| AMGN | Amgen Inc | $465.67 | -0.30% | 26.9 | 252.64B |
| GILD | Gilead Sciences Inc | $168.08 | +0.08% | — | 208.95B |
| VRTX | Vertex Pharmaceuticals Inc | $538.60 | -0.74% | 33.9 | 134.82B |
| REGN | Regeneron Pharmaceuticals | $955.47 | +0.45% | 20.4 | 98.38B |
| ALNY | Alnylam Pharmaceuticals Inc | $165.04 | +5.36% | 7.7 | 20.98B |